Anti-Tissue Factor Antibodies and Compositions with Enhanced Effector Function
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 18, 2008
app pub date -
Apr 28, 2008
filing date -
Apr 30, 2007
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
Variants of antibodies to human tissue factor are optimized for the capability to elicit effector functions produced by immune effector cells while maintaining the ability to neutralize the biological functions of tissue factor, such as the prevention of blood clotting via the extrinsic pathway, and are produced by mutations of the Fc-region of the antibody. The variants comprise A330Y, A330I, and I332E where the I332E variant may optionally further comprise a second substitution selected from A330I (in the case of the first substitution being I332E), V264I, and S239D. The variants may further be optimized for the capability to elicit effector functions produced by immune effector cells by production of the antibody variants under conditions that produce effector function enhancing glycosylation of the Fc-region.
First Claim
all claims..Other Claims data not available
Family
Country | kind | publication No. | Filing Date | Type | Sub-Type |
---|---|---|---|---|---|
EP | A1 | EP2148929 | Apr 28, 2008 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
APPLICATION PUBLISHED WITH SEARCH REPORT | ANTI-TISSUE FACTOR ANTIBODIES AND COMPOSITIONS WITH ENHANCED EFFECTOR FUNCTION | Feb 03, 2010 | |||
WO | A1 | WO2008137382 | Apr 28, 2008 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
INTERNATIONAL APPLICATION PUBLISHED WITH INTERNATIONAL SEARCH REPORT | ANTI-TISSUE FACTOR ANTIBODIES AND COMPOSITIONS WITH ENHANCED EFFECTOR FUNCTION | Nov 13, 2008 | |||
CA | A1 | CA2685698 | Apr 28, 2008 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
APPLICATION LAID OPEN | ANTI-TISSUE FACTOR ANTIBODIES AND COMPOSITIONS WITH ENHANCEDEFFECTOR FUNCTION | Nov 13, 2008 | |||
JP | A | JP2010525820 | Apr 28, 2008 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
Published unexamined patent application | ANTI-TISSUE FACTOR ANTIBODIES AND COMPOSITIONS WITH ENHANCED EFFECTOR FUNCTION | Jul 29, 2010 |
- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
CENTOCOR INC | 145 KING OF PRUSSIA ROAD RADNOR PA 19087 |
International Classification(s)
- A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
- C07H:SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTI....
- C12N:MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF
- A01K:ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; ....
- A61P:THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDI....
- C07K:PEPTIDES

Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Anderson, Glenn M | Radnor, PA | 6 | 52 |
# of filed Patents : 6 Total Citations : 52 | |||
Scallon, Bernard | Radnor, PA | 59 | 1198 |
# of filed Patents : 59 Total Citations : 1198 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 17 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
